- Home
- EMD vs VSTM Comparison
EMD vs VSTM Comparison
Compare EMD & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- VSTM
- Stock Information
- Founded
- EMD 2003
- VSTM 2010
- Country
- EMD United States
- VSTM United States
- Employees
- EMD N/A
- VSTM N/A
- Industry
- EMD Finance/Investors Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- EMD Finance
- VSTM Health Care
- Exchange
- EMD Nasdaq
- VSTM Nasdaq
- Market Cap
- EMD 604.6M
- VSTM 598.2M
- IPO Year
- EMD N/A
- VSTM 2012
- Fundamental
- Price
- EMD $10.48
- VSTM $9.59
- Analyst Decision
- EMD
- VSTM Strong Buy
- Analyst Count
- EMD 0
- VSTM 9
- Target Price
- EMD N/A
- VSTM $13.38
- AVG Volume (30 Days)
- EMD 248.5K
- VSTM 2.5M
- Earning Date
- EMD 01-01-0001
- VSTM 11-05-2025
- Dividend Yield
- EMD 10.25%
- VSTM N/A
- EPS Growth
- EMD N/A
- VSTM N/A
- EPS
- EMD N/A
- VSTM N/A
- Revenue
- EMD N/A
- VSTM $2,137,000.00
- Revenue This Year
- EMD N/A
- VSTM $86.06
- Revenue Next Year
- EMD N/A
- VSTM $395.22
- P/E Ratio
- EMD N/A
- VSTM N/A
- Revenue Growth
- EMD N/A
- VSTM N/A
- 52 Week Low
- EMD $7.85
- VSTM $2.54
- 52 Week High
- EMD $9.55
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- EMD 52.26
- VSTM 53.38
- Support Level
- EMD N/A
- VSTM N/A
- Resistance Level
- EMD $10.49
- VSTM $10.04
- Average True Range (ATR)
- EMD 0.08
- VSTM 0.61
- MACD
- EMD -0.37
- VSTM -0.49
- Stochastic Oscillator
- EMD 99.90
- VSTM 85.78
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.